{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:42:32Z","timestamp":1765827752513,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00784-019-02828-w","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T01:53:17Z","timestamp":1549936397000},"page":"3967-3975","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8603-6527","authenticated-orcid":false,"given":"Kelly","family":"McGowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Acton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saso","family":"Ivanovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Newell W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,12]]},"reference":[{"issue":"10","key":"2828_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72(10):1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"2828_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00774-010-0162-7","volume":"28","author":"T Yoneda","year":"2010","unstructured":"Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M (2010) Bisphosphonate-related osteonecrosis of the jaw: position paper from the allied task force committee of Japanese society for bone and mineral research, Japan osteoporosis society, Japanese society of periodontology, Japanese society for oral and maxillofacial radiology, and Japanese society of oral and maxillofacial surgeons. J Bone Miner Metab 28(4):365\u2013383","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"2828_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jpor.2014.08.001","volume":"59","author":"K Niibe","year":"2015","unstructured":"Niibe K, Ouchi T, Iwasaki R, Nakagawa T, Horie N (2015) Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab. J Prosthodont Res 59(1):3\u20135","journal-title":"J Prosthodont Res"},{"issue":"4","key":"2828_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","volume":"66","author":"PP Sedghizadeh","year":"2008","unstructured":"Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW (2008) Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 66(4):767\u2013775","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"2828_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K McGowan","year":"2018","unstructured":"McGowan K, McGowan T, Ivanovski S (2018) Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis 24(4):527\u2013536","journal-title":"Oral Dis"},{"issue":"32","key":"2828_CR6","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","volume":"27","author":"K Vahtsevanos","year":"2009","unstructured":"Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis CG, Boukovinas I, Koloutsos GE, Teleioudis Z, Kitikidou K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27(32):5356\u20135362","journal-title":"J Clin Oncol"},{"issue":"12","key":"2828_CR7","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/annonc\/mdm370","volume":"18","author":"F Jadu","year":"2007","unstructured":"Jadu F, Lee L, Pharoah M, Reece D, Wang L (2007) A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients. Ann Oncol 18(12):2015\u20132019","journal-title":"Ann Oncol"},{"issue":"6","key":"2828_CR8","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1359\/jbmr.080205","volume":"23","author":"AO Hoff","year":"2008","unstructured":"Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K (2008) Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23(6):826\u2013836","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2828_CR9","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","volume":"28","author":"T Hasegawa","year":"2017","unstructured":"Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, Kondou E, Takeda D, Kojima Y, Sato S (2017) A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int 28(8):2465\u20132473","journal-title":"Osteoporos Int"},{"issue":"8","key":"2828_CR10","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.joms.2013.02.016","volume":"71","author":"C Tsao","year":"2013","unstructured":"Tsao C, Darby I, Ebeling PR, Walsh K, O\u2019Brien-Simpson N, Reynolds E, Borromeo G (2013) Oral health risk factors for bisphosphonate-associated jaw osteonecrosis. J Oral Maxillofac Surg Surg 71(8):1360\u20131366","journal-title":"J Oral Maxillofac Surg Surg"},{"issue":"4","key":"2828_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0022034510397196","volume":"90","author":"A Barasch","year":"2011","unstructured":"Barasch A, Cunha-Cruz J, Curro F, Hujoel P, Sung A, Vena D, Voinea-Griffin A, Group CC (2011) Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN. J Dent Res 90(4):439\u2013444","journal-title":"J Dent Res"},{"issue":"8","key":"2828_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1634\/theoncologist.2008-0091","volume":"13","author":"CL Estilo","year":"2008","unstructured":"Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A (2008) Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist 13(8):911\u2013920","journal-title":"Oncologist"},{"issue":"6","key":"2828_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ajoms.2015.03.005","volume":"27","author":"A Matsui","year":"2015","unstructured":"Matsui A, Kurihara J, Morishima H, Suzuki H, Sato S, Yamauchi K, Takahashi T (2015) Medication related osteonecrosis of the jaw (MRONJ): a retrospective survey of a series of patients treated according to the AAOMS guidelines. J Oral Maxillofac Surg Med Pathol 27(6):757\u2013763","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"issue":"4","key":"2828_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ypmed.2007.08.012","volume":"45","author":"E Elm Von","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med 45(4):247\u2013251","journal-title":"Prev Med"},{"issue":"1","key":"2828_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"C Ripamonti","year":"2008","unstructured":"Ripamonti C, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E (2008) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 20(1):137\u2013145","journal-title":"Ann Oncol"},{"key":"#cr-split#-2828_CR16.1","unstructured":"Australian Bureau of Statistics [ABS], Census of population and housing: Socio-economic indexes for areas (SEIFA), Australia, 2016. Canberra: Australian Bureau of Statistic, 2018. [Updated 2018 March 27"},{"key":"#cr-split#-2828_CR16.2","unstructured":"cited 2018 July 30]. Available from:  http:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/mf\/2033.0.55.001"},{"issue":"1","key":"2828_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"M Dimopoulos","year":"2008","unstructured":"Dimopoulos M, Kastritis E, Bamia C, Melakopoulos I, Gika D, Roussou M, Migkou M, Eleftherakis-Papaiakovou E, Christoulas D, Terpos E (2008) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol 20(1):117\u2013120","journal-title":"Ann Oncol"},{"issue":"10","key":"2828_CR18","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jcms.2016.07.026","volume":"44","author":"T M\u00fccke","year":"2016","unstructured":"M\u00fccke T, Deppe H, Hein J, Wolff KD, Mitchell DA, Kesting MR, Retz M, Gschwend JE, Thalgott M (2016) Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid \u2013 a prospective study over 6 years. J Craniomaxillofac Surg 44(10):1689\u20131693","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"2828_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3\u201323","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2828_CR20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5694\/j.1326-5377.2010.tb03835.x","volume":"193","author":"PN Sambrook","year":"2010","unstructured":"Sambrook PN, Chen JS, Simpson JM, March LM (2010) Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality. Med J Aust 193(3):154\u2013156","journal-title":"Med J Aust"},{"issue":"2","key":"2828_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.11622\/smedj.2018014","volume":"59","author":"BH Chan","year":"2018","unstructured":"Chan BH, Yee R, Puvanendran R, Ang S (2018) Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management. Singap Med J 59(2):70\u201375","journal-title":"Singap Med J"},{"issue":"5","key":"2828_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.11622\/smedj.2018057","volume":"59","author":"CL Toh","year":"2018","unstructured":"Toh CL, Dutton A (2018) Comment on: medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management. Singap Med J 59(5):287","journal-title":"Singap Med J"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-019-02828-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-019-02828-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-019-02828-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T19:08:48Z","timestamp":1583262528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-019-02828-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,12]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["2828"],"URL":"https:\/\/doi.org\/10.1007\/s00784-019-02828-w","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"type":"print","value":"1432-6981"},{"type":"electronic","value":"1436-3771"}],"subject":[],"published":{"date-parts":[[2019,2,12]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"K McGowan has received a speaker honorarium from Eli Lilly. RS Ware declares that he has no conflict of interest. C Acton declares that she has no conflict of interest. S Ivanovski declares that he has no conflict of interest. NW Johnson declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}